New pharmaceutical legislation focusing on access to medicine and sustainability
On 26 April 2023 the European Commission has put forth a proposal for a new Directive and new Regulation that will revise and replace the existing general pharmaceutical legislation.
The proposal has been long-awaited and has been created as a part of the Pharmaceutical Strategy for Europe adopted back in 2020.
According to the European Commission the intention is to establish a regulatory framework that:
- Ensures access to affordable medicines for patients, and addressing unmet medical needs
- Supports competitiveness, innovation and sustainability of the EU’s pharmaceutical industry and the development of high quality, safe, effective and greener medicines
- Enhance crisis preparedness and response mechanisms, diversified and secure supply chains, addressing medicines shortages, and
- Ensures a strong EU voice in the world, by promoting a high level of quality, efficacy and safety standards
Want to know more?
Plesner has a dedicated Life Science team specifically focusing on examining the new proposal and closely following its development. If you are interested in sparring and/or a brief introduction to the new proposal don’t hesitate to reach out.
For further information see the Commission's website
Read the new proposed Regulation
Read the new proposed Directive